Cargando…
Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift
Palliation of symptoms related to malignancy-associated hypercalcemia (MAH) is essential and clinically meaningful for patients, given the continued poor prognosis, with high morbidity and mortality associated with this disease process. Historically, agents have been temporizing, having no impact on...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923058/ https://www.ncbi.nlm.nih.gov/pubmed/33289687 http://dx.doi.org/10.1530/EC-20-0487 |